Funded Tech Companies
HighTide Therapeutics
HighTide Therapeutics is a biopharmaceutical company, located in Shenzhen. Venture capital investment came from Yuthai Fund, Guangzhou Yuexiu Industrial Investment Fund and China Development Bank Capital.
Company Overview
Company Name
HighTide Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
18B-102, Zhonghaixin, Ganli 2nd Road, Longgang District,
Shenzhen, 518112
CN
Shenzhen, 518112
CN
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
HighTide Therapeutics is a globally integrated clinical-stage biopharmaceutical company focusing on the discovery and development of novel multifunctional therapies for metabolic and digestive diseases with significant unmet medical needs. The company's lead drug candidate, HTD1801, is a first-in-class new molecular entity, currently in clinical development for the treatment of type 2 diabetes (T2DM), non-alcoholic steatohepatitis (NASH), severe hypertriglyceridemia (SHTG), and primary sclerosing cholangitis (PSC). HTD1801 has received Fast Track designation from the US FDA for both NASH and PSC, as well as Orphan Drug designation for PSC. In China, HTD1801 has been included in the National Major New Drug Innovation Program.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/5/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Liping Liu
Vice President
Jin Chen
Company Investors
Browse more funded tech companies:
Share this article
About Our Venture Capital Transactions Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs